Latest Research

October 2017: Pulmonary Arterial Hypertension Is Common Complication in Lupus Patients – This study found that nearly 1 in 10 people with SLE develop Pulmonary Arterial Hypertension, a condition where the blood pressure in the arteries that go from the heart to the lungs is too high. There were also some interesting findings on early diagnosis of this fatal condition.

October 2017: Rituximab Could Be Alternative in Neurological SLE – An Italian case report shows that Rituxan may be a viable course of treatment for lupus patients with neurological and psychiatric manifestations.

October 2017: UK Releases New Guidelines For Lupus Management – It discusses baseline for diagnosis and breaks treatment guidelines down by mild, moderate and severe cases of lupus.

October 2017: Amgen’s AMG 811 Fails to Improve Lupus Outcomes in Phase 1 Trial – Lupus patients (with and without lupus nephritis) being treated with Amgen‘s anti-interferon-gamma antibody, AMG 811 showed little to no improvement in a Phase 1b clinical trial.

October 2017: Probiotics Could Help Reduce Kidney Inflammation in Lupus Patients – Research has found that adding Lactobacillus to the diet can be a natural way to reduce kidney inflammation in lupus patients.

March 2017: Use of SLICC Criteria In Lupus Registry Enables SLE Classification Of ACR-Designated Subjects With Incomplete Lupus – Of 3575 patients classified with SLE under one system (either Systemic Lupus International Collaborating Clinics or American College of Rheumatology), 3312 (92.6%) met the criteria for SLE under both systems. This study breaks down the differences and who each system falls short at encompassing. I have both classification systems criteria listed in the About Lupus section for anyone curious.